Who has invested in MiNA Therapeutics?

Eli Lilly are named among the investors backing MiNA Therapeutics.

MiNA Therapeutics Funding: $45M Raised, Series A (2020)

MiNA Therapeutics funding overview

MiNA Therapeutics is based in London, United Kingdom. MiNA Therapeutics has raised $45M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2020. The round record for MiNA Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Eli Lilly.

MiNA Therapeutics at a glance

Total raised: $45M
Latest round: Series A
Latest round date: September 2020
Headquarters: London, United Kingdom
Notable investors: Eli Lilly

Frequently asked about MiNA Therapeutics funding

How much has MiNA Therapeutics raised?: MiNA Therapeutics has raised $45M in total disclosed funding across the rounds on record.
Who has invested in MiNA Therapeutics?: Eli Lilly are named among the investors backing MiNA Therapeutics.
What was the latest MiNA Therapeutics funding round?: The most recent disclosed round is a Series A, announced in September 2020.
Where is MiNA Therapeutics based?: MiNA Therapeutics is based in London, United Kingdom.
When did MiNA Therapeutics last raise?: The last disclosed MiNA Therapeutics round closed in September 2020 at Series A.

Totals shown for MiNA Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in London and the investors behind them below.

MiNA Therapeutics Funding: $45M Raised, Series A (2020)

MiNA Therapeutics funding overview

MiNA Therapeutics at a glance

Frequently asked about MiNA Therapeutics funding

Companies related to MiNA Therapeutics (31)

Browse related funding lists (6)